The Global Medical Director, Early Assets will report to the VP, Early Assets and will be responsible for developing, leading, and executing the medical strategy and scientific engagement for multiple early-stage CNS…
Overview: We are seeking an experienced Medical Science Liaison (MSL) to join the TTR team and support Alnylam’s commitment to advancing the science and care of patients with transthyretin (TTR) amyloidosis. Patients…
Overview Alnylam Pharmaceuticals is seeking an imaginative physician drug developer. This is an opportunity to provide clinical leadership in developing RNAi therapeutics in Alnylam’s rapidly expanding portfolio, which…
Connect over MCP — free, no account needed to search.